InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.9859
-0.0341 (-3.34%)
At close: Jan 12, 2026, 4:00 PM EST
0.9859
0.00 (0.00%)
After-hours: Jan 12, 2026, 7:04 PM EST
InterCure Market Cap
InterCure has a market cap or net worth of $55.54 million as of January 12, 2026. Its market cap has decreased by -12.88% in one year.
Market Cap
55.54M
Enterprise Value
96.42M
1-Year Change
-12.88%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $55.54M, an increase of 3,018.23%. That is a compound annual growth rate of 25.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 54.60M | -1.63% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |